← FDA DRUG APPROVALS

FDA ANDA · ANDA070629

IBUPROFEN

Sponsor: LEDERLE

APPLICATION
ANDA070629
TYPE
ANDA
ORIGINAL APPROVAL
1986-09-19
LATEST ACTION
1992-05-05
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

IBUPROFENDiscontinued
IBUPROFEN 400MG · TABLET · ORAL

Approval history

1992-05-05Labeling · Supplement 8AP
1992-04-22Labeling · Supplement 7AP
1989-09-27Labeling · Supplement 6AP
1989-03-16Labeling · Supplement 5AP
1988-07-06Labeling · Supplement 4AP
1987-03-20Labeling · Supplement 3AP
1987-02-19Labeling · Supplement 2AP
1986-09-19OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →